Bio-Rad 연구소, Inc.
US ˙ NYSE ˙ US0905722072

SecurityBIO / Bio-Rad Laboratories, Inc.
InstitutionAdvisor Group, Inc.
Latest Disclosed Ownership4,500 shares
Latest Disclosed Value $ 1,666,000
Advisor Group, Inc. reports 76.13% increase in ownership of BIO / Bio-Rad Laboratories, Inc.

On February 12, 2020 - Advisor Group, Inc. filed a 13F-HR form disclosing ownership of 4,500 shares of Bio-Rad Laboratories, Inc. (US:BIO) valued at $1,665,135 USD as of December 31, 2019. The entity filed a previous 13F-HR on November 13, 2019 disclosing 2,555 shares of Bio-Rad Laboratories, Inc.. This represents a change in shares of 76.13% during the quarter. The current value of the position is $1,324,440 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2020-02-12 2019-12-31 13F BIO RAD LABS CL A 090572207 4,500 1,945 76.13 1,666 95.77 0.0115
2019-11-13 2019-09-30 13F BIO RAD LABS CL A 090572207 2,555 245 10.61 851 17.87 0.0063
2019-07-31 2019-06-30 13F BIO RAD LABS CL A 090572207 2,310 231 11.11 722 13.70 0.0055
2019-05-09 2019-03-31 13F BIO RAD LABS CL A 090572207 2,079 -1,316 -38.76 635 -19.52 0.0052
2019-02-11 2018-12-31 13F BIO RAD LABS CL A 090572207 3,395 -198 -5.51 789 -29.80 0.0077
2018-11-14 2018-09-30 13F BIO RAD LABS CL A 090572207 3,593 1,547 75.61 1,124 90.51 0.0113
2018-08-13 2018-06-30 13F BIO RAD LABS CL A 090572207 2,046 150 7.91 590 24.21 0.0081
2018-05-15 2018-03-31 13F BIO RAD LABS CL A 090572207 1,896 40 2.16 475 7.22 0.0065
2018-02-14 2017-12-31 13F BIO RAD LABS CL A 090572207 1,856 -256 -12.12 443 -5.74 0.0059
2017-11-06 2017-09-30 13F BIO RAD LABS CL A 090572207 2,112 1,160 121.85 470 117.59 0.0074
2017-11-03 2017-06-30 13F/A-1 BIO RAD LABS CL A 090572207 952 144 17.82 216 33.33 0.0038
2017-08-11 2017-06-30 13F BIO RAD LABS CL A 090572207 952 144 216
2017-11-02 2017-03-31 13F/A-1 BIO RAD LABS CL A 090572207 808 -18 -2.18 162 8.00 0.0033
2017-05-15 2017-03-31 13F BIO RAD LABS CL A 090572207 808 -18 162
2017-11-02 2016-12-31 13F/A-1 BIO RAD LABS CL A 090572207 826 58 7.55 150 19.05 0.0034
2017-01-31 2016-12-31 13F BIO RAD LABS CL A 090572207 826 58 150
2017-11-02 2016-09-30 13F/A-1 BIO RAD LABS CL A 090572207 768 2 0.26 126 16.67 0.0030
2016-11-08 2016-09-30 13F BIO RAD LABS CL A 090572207 768 2 126
2016-08-11 2016-06-30 13F BIO RAD LABS COM 090572207 766 108
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.